The opportunity to join a clinical trial can not only be very beneficial for transplant patients but help clinicians identify the best possible approach for future treatments.
However, setting up and delivering clinical trials can be a painstaking process. Blood cancer and transplant trials can be particularly challenging because of the range of individual blood disorders, and because patients must meet very specific criteria to take part.
This is why Anthony Nolan is a funding partner of IMPACT, the UK’s stem cell transplant clinical trials partnership. The platform makes it quicker and easier to conduct important clinical trials and research within the field of stem cell transplantation.
IMPACT delivers much-needed infrastructure that will make it easier to set up clinical trials, recruit patients and share data. Through their operational hub, a nationwide network of 22 transplant centres recruit and support patients and work with the hub who support the running of the clinical trials. It is referred to as a ‘hub and spoke’ model and has helped to decrease the setup times of trials, increase patient recruitment levels and deliver new insights into transplantation.
If you want to find out more about the partnership, please visit our clinical research page.